Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析

◆英語タイトル:Zynex Inc (ZYXI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH34280FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥85,200見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥127,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zynex Inc (Zynex) formerly Zynex Medical Inc operates as a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular elect2ical stimulation device; and NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. It also offers Comfortrac for cervical traction; JetStream for hot and cold therapy; and Aspen LSO Back Braces for lumbar support. Zynex offers products for home use, cardiac monitoring and EMG and EEG diagnostic purposes in the neurology clinical market. The company markets its products through a network of medical distributors. Zynex is headquartered in Englewood, Colorado, the US.

Zynex Inc Key Recent Developments

Feb 25,2021: Zynex announces 2020 fourth quarter and full year earnings
Feb 18,2021: Zynex Schedules 2020 Fourth Quarter and Full-Year Earnings Call
Jan 28,2021: Zynex appoints Anna Lucsok as Chief Operating Officer of Zynex Medical
Jan 14,2021: Zynex announces filing of patent for sepsis monitor
Jan 12,2021: Zynex announces 117% year over year order growth and increases adjusted EBITDA estimate

This comprehensive SWOT profile of Zynex Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zynex Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Zynex Inc – Key Information
Zynex Inc – Overview
Zynex Inc – Key Employees
Zynex Inc – Key Employee Biographies
Zynex Inc – Key Operational Heads
Zynex Inc – Major Products and Services
Zynex Inc – History
Zynex Inc – Company Statement
Zynex Inc – Locations And Subsidiaries
Zynex Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Zynex Inc – Business Description
Zynex Inc – Corporate Strategy
Zynex Inc – SWOT Analysis
SWOT Analysis – Overview
Zynex Inc – Strengths
Zynex Inc – Weaknesses
Zynex Inc – Opportunities
Zynex Inc – Threats
Zynex Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Zynex Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Zynex Inc, Key Information
Zynex Inc, Key Ratios
Zynex Inc, Share Data
Zynex Inc, Major Products and Services
Zynex Inc, History
Zynex Inc, Key Employees
Zynex Inc, Key Employee Biographies
Zynex Inc, Key Operational Heads
Zynex Inc, Other Locations
Zynex Inc, Subsidiaries
Zynex Inc, Key Competitors
Zynex Inc, SWOT Analysis
Zynex Inc, Ratios based on current share price
Zynex Inc, Annual Ratios
Zynex Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sino-Ocean Group Holding Limited:企業の戦略・SWOT・財務情報
    Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report Summary Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Ashoka Buildcon Ltd (ASHOKA):企業の財務・戦略的SWOT分析
    Ashoka Buildcon Ltd (ASHOKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Rizal Commercial Banking Corp (RCB):企業の財務・戦略的SWOT分析
    Summary Rizal Commercial Banking Corp (RCBC) is a commercial and financial banking service provider that offers corporate, commercial, and consumer banking, cash management, treasury, and remittance products and services. The company’s electronic banking services include mobile banking, internet ban …
  • PharmAust Ltd (PAA):企業の財務・戦略的SWOT分析
    Summary PharmAust Ltd (PAA) is a clinical-stage company that focuses on the development of targeted cancer therapeutics for the treatment of human and veterinary cancers. The company’s lead product candidate Monepantel is a small molecule that has been developed to treat parasite infections in food …
  • Hindustan Construction Co Ltd (HCC):企業の財務・戦略的SWOT分析
    Hindustan Construction Co Ltd (HCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Coherus BioSciences Inc (CHRS):企業の財務・戦略的SWOT分析
    Summary Coherus BioSciences Inc (Coherus) is a biosimilar platform company that develops and commercializes biosimilar drugs. The company’s pipeline product candidates include CHS-1701, an pegfilgrastim used to treat febrile neutropenia; CHS-0214, is an etanercept biosimilar candidate which is used …
  • Bullfrog Power Inc.-エネルギー分野:企業M&A・提携分析
    Summary Bullfrog Power Inc. (Bullfrog Power) is a provider of green energy. The company offers renewable energy solutions that help businesses and houses in reducing their environmental impact. Bullfrog's product portfolio includes green electricity, green fuel and green natural gas. The company, th …
  • Liebherr-International AG:企業の戦略・SWOT・財務分析
    Liebherr-International AG - Strategy, SWOT and Corporate Finance Report Summary Liebherr-International AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sonoma Orthopedic Products Inc-医療機器分野:企業M&A・提携分析
    Summary Sonoma Orthopedic Products Inc (Sonoma) is a medical device company that offers orthopedic products. The company provides long bone fixation system that reduces fixation time and patient discomfort. Its product include ankle pin, collarbone pin and wrist pin. Sonoma provides treatment for wr …
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • RegenxBio Inc (RGNX):製薬・医療:M&Aディール及び事業提携情報
    Summary RegenxBio Inc (RegenxBio), formerly ReGenX Biosciences LLC is a provider of therapeutics for various diseases. The company develops, commercializes and licenses recombinant adeno-associated virus (AAV) gene therapy. Its products include AAV plasmids, AAV vector reporter systems and custom AA …
  • MKB Private Banking:企業の戦略・SWOT・財務分析
    MKB Private Banking - Strategy, SWOT and Corporate Finance Report Summary MKB Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hunan Corun New Energy Co Ltd (600478):電力:M&Aディール及び事業提携情報
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries, among others. It also manufactures ultra-inte …
  • Earle M. Jorgensen Company:企業の戦略・SWOT・財務情報
    Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report Summary Earle M. Jorgensen Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • OGD2 Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary OGD2 Pharma SAS (OGD2 Pharma) is an independent pre-clinical stage biotechnology company that researches, develops and commercializes cancer immunotherapies targeting the O-acetylated form of the GD2 ganglioside (OAcGD2). The company pipeline product portfolio includes OGD201, a humanized mo …
  • SGL Carbon SE:企業の戦略・SWOT・財務情報
    SGL Carbon SE - Strategy, SWOT and Corporate Finance Report Summary SGL Carbon SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Eickhoff Corporation:企業の戦略・SWOT・財務分析
    Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report Summary Eickhoff Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract rese …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆